title: Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms. Reply to Pouwer F [letter].
authors.affiliation: Netherlands Comprehensive Cancer Organisation, P.O. Box 231, 5600 AE, Eindhoven, the Netherlands, m.zanders@iknl.nl.
authors.forename: Marjolein M J
authors.initials: MM
authors.lastname: Zanders
authors.forename: Harm R
authors.initials: HR
authors.lastname: Haak
authors.forename: Myrthe P P
authors.initials: MP
authors.lastname: van Herk-Sukel
authors.forename: Lonneke V
authors.initials: LV
authors.lastname: van de Poll-Franse
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Johnson
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D055118:Medication Adherence / Q000523:psychology*; D009369:Neoplasms / Q000175:diagnosis*
chemical_list: D007004:Hypoglycemic Agents
references.citation: Diabetes Care. 2014 Jan;37 Suppl 1:S14-80
references.pmid: 24357209
references.citation: Diabetologia. 2015 May;58(5):951-60
references.pmid: 25638246
references.citation: Diabetologia. 2015 Jun;58(6):1378-9
references.pmid: 25773406